Claims for Patent: 11,679,086
✉ Email this page to a colleague
Summary for Patent: 11,679,086
| Title: | Systems comprising a composite backing and methods for long term transdermal administration |
| Abstract: | Devices, systems, compositions and methods for long term or prolonged transdermal administration of an active agent are provided. |
| Inventor(s): | Eun Soo Lee, Amit K. Jain, Parminder Singh |
| Assignee: | Corium LLC |
| Application Number: | US17/200,481 |
| Patent Claims: |
1. A method for treating Alzheimer's disease, comprising: providing a transdermal patch comprised of a composite backing layer comprised of (i) a first layer comprised of a polymer fabric or a polymer film having a stretchability of at least 5% in at least one direction; (ii) a second layer comprised of one or more adhesive polymers; and (iii) a third layer comprised of one or more polymer films; wherein the first and second layers are in contact and the second and third layers are in contact, and wherein the third layer comprises cuts formed at least partially through the layer; and an adhesive matrix drug layer laminated to the third layer, the adhesive matrix drug layer comprising a drug. 2. The method of claim 1, further comprising instructing to apply the transdermal patch to skin for delivery of the drug. 3. The method of claim 1, wherein the polymer fabric or polymer film of the first layer is comprised of one or more polymers selected from polyesters, polyethylenes, polypropylenes, polyvinylchloride, polyethylene vinyl acetate or copolymers thereof, and polyurethanes. 4. The method of claim 1, wherein the first layer is selected from a woven polymer fabric, a non-woven polymer fabric, a polymer laminate, and a polymer/metal laminate. 5. The method of claim 1, wherein the first layer has a thickness of about 0.5-10 mil. 6. The method of claim 1, wherein one or more of the polymers of the second layer has at least one of (i) a tensile strength of less than 10 MPa and (ii) an elongation of at least 50%. 7. The method of claim 1, wherein the one or more adhesive polymers of the second layer are selected from acrylates, acrylate copolymers, polyisobutylene, silicone, polystyrene butyl rubber, polyethylene vinyl acetate and copolymers thereof, and plasticized polymers. 8. The method of claim 1, wherein the second layer has a thickness of about 0.5-30 mil. 9. The method of claim 1, wherein the third layer has a thickness of about 1-40 mil. 10. The method of claim 1, wherein the drug is donepezil. 11. The method of claim 1, wherein the first layer, second layer, and third layer are laminated. 12. The method of claim 1, wherein the third layer is a laminate of two polymer films. 13. A method for delivery of donepezil through skin, comprising: providing a transdermal patch comprised of a composite backing layer comprising (i) a first layer comprised of a polymer fabric or a polymer film having a stretchability of at least 5% in at least one direction; (ii) a second layer comprised one or more adhesive polymers; and (iii) a third layer comprised of one or more polymer films, wherein the third layer comprises cuts formed at least partially through the layer; wherein the first layer, second layer, and third layers are arranged in contact as a composite; (iv) an adhesive drug layer comprising donepezil, the adhesive drug layer laminated to the third layer; and (v) a release liner; wherein donepezil is delivered through skin upon removal of the release liner and application of the transdermal patch to skin. 14. The method of claim 13, wherein the first layer polymer fabric or polymer film is comprised of one or more polymers selected from polyesters, polyethylenes, polypropylenes, polyvinylchloride, polyethylene vinyl acetate or copolymers thereof, and polyurethanes. 15. The method of claim 13, wherein the first layer is selected from an occlusive polymer film, a polymer laminate, a polymer/metal laminate, a breathable polymer film, a woven polymer fabric and a non-woven polymer fabric. 16. The method of claim 13, wherein the first layer has a thickness of about 0.5-10 mil. 17. The method of claim 13, wherein the one or more polymers of the second layer are selected from acrylates, acrylate copolymers, polyisobutylene, silicone, polystyrene butyl rubber, polyethylene vinyl acetate and copolymers thereof, and plasticized polymers. 18. The method of claim 13, wherein the second layer has a thickness of about 0.5-30 mil. 19. The method of claim 13, wherein the third layer has a thickness of about 1-40 mil. 20. The method of claim 13, wherein the release liner is formed of a material selected from a silicone coated polyethylene terephthalate, a fluorocarbon, a fluorocarbon coated polyethylene terephthalate, and a fluorosilicone coated polyethylene terephthalate. 21. A method for treating Alzheimer's disease in a subject, comprising: applying a transdermal patch to skin of the subject, wherein the transdermal patch comprises a composite backing layer comprised of (i) a first layer comprised of a polymer fabric or a polymer film having a stretchability of at least 5% in at least one direction; (ii) a second layer comprised of one or more adhesive polymers; and (iii) a third layer comprised of one or more polymer films; wherein the first and second layers are in contact and the second and third layers are in contact, and wherein the third layer comprises cuts formed at least partially through the layer; and an adhesive matrix drug layer laminated to the third layer, the adhesive matrix drug layer comprising a drug. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
